Obesity Surgery Devices Market 2022
New Research Report “Obesity Surgery Devices Market, Industrial Analysis, Market Dynamics, Growth Analysis, Regional Analysis, Size, Share, and Forecast 2022- 2027”.
Market Overview
The study of market analysis of the Obesity Surgery Devices Market focuses on the key elements and the market dynamics of a specific market within that industry. Obesity Surgery Devices Market study is an essential part of the industry analysis that focuses on the aspects associated with the SWOT analysis. The survey report analyses the elements, such as the strengths, weaknesses, opportunities, and threats of every individual manufacturing company.
Persistence Market Research Released New Market Report on “Global Market Study on Obesity Surgery Devices: Asia-Pacific to Witness Highest Growth by 2027” the global obesity surgery devices market was valued at USD 1,432.4 million in 2022 and is expected to grow at a CAGR of 9.6% from 2022 to 2027, to reach an estimated value of USD 2,489.5 million in 2027.
Get Sample Copy of this Report@ https://www.persistencemarketresearch.com/samples/2894
Globally, the obesity surgery devices market is witnessing significant growth due to increasing obesity epidemic and increasing sedentary lifestyle and junk food habits. Increasing prevalence of obesity among children and adults is posing a threat in both developed and developing nations. Excess body weight directly contributes to increasing risk of stroke, heart diseases, type-2 diabetes and some forms of cancer.
Some of the major players in the obesity surgery devices market:
- Johnson & Johnson.
- Medtronic, Inc.
- Apollo Endosurgery Inc.
- Aspire Bariatrics.
- Spatz FGIA Inc.
- MetaCure.
- IntraPace Inc.
- Other.
Request for Methodology@ https://www.persistencemarketresearch.com/methodology/2894
Obesity surgery is a broadly available treatment for persons with severe and complex obesity. However, inadequate insurance coverage for the procedure and excessive cost of surgery often makes it unaffordable. In addition, selective nature of obesity surgery, due to its complications, restricts growth of obesity surgery devices market. The global obesity surgery device market is estimated at USD 1,432.4 million in 2014. It is likely to grow at a CAGR of 9.6% from 2014 to 2020 to reach USD 2,489.5 million in 2020.
North America is facing serious public health problems due to obesity. The U.S. accounted for 13% of obese persons worldwide in 2013. Similarly, according to the Centers for Disease Control and Prevention (CDC), 24.5% of Americans were suffering from obesity in 2004 and this increased to 35.7% in 2011. In 2011, Roux-en-Y gastric bypass was the most common procedure in North America.
In Europe, obesity is a major public health challenge in Europe. According to the Organization for Economic Co-operation and Development (OECD) in 2010, approximately 52% of the population in the European Union was obese or overweight.
However, in Asia obesity has reached epidemic proportions in many countries in Asia Pacific. South East Asia and Western Pacific regions are facing an epidemic of obesity-associated diseases such as cardiovascular disorders and diabetes. China and India accounted for around 15% of the world’s obese population worldwide in 2013.
Access Full Report@ https://www.persistencemarketresearch.com/checkout/2894
The obesity surgery devices market is segmented as follows:
Obesity Surgery Devices Market, By Procedure
- Roux-en-Y Gastric Bypass
- Sleeve Gastrectomy
- Adjustable Gastric banding
- Biliopancreatic diversion with duodenal switch
Obesity Surgery Devices Market, By Devices
- Intragastric Balloons
- Gastric Electrical Stimulation
- Gastric Bands
- Staples
Contact Us:
Persistence Market Research
Address – 305 Broadway, 7th Floor, New York City, NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353
Sales – sales@persistencemarketresearch.com